Sutro Biopharma Inc.

0.90
0.18 (24.17%)
At close: Apr 23, 2025, 3:59 PM
0.90
0.16%
After-hours: Apr 23, 2025, 07:55 PM EDT

Sutro Biopharma Statistics

Share Statistics

Sutro Biopharma has 84.36M shares outstanding. The number of shares has increased by 2.42% in one year.

Shares Outstanding 84.36M
Shares Change (YoY) 2.42%
Shares Change (QoQ) 1.6%
Owned by Institutions (%) 77.67%
Shares Floating 76.02M
Failed to Deliver (FTD) Shares 40
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 5.36M, so 6.4% of the outstanding shares have been sold short.

Short Interest 5.36M
Short % of Shares Out 6.4%
Short % of Float 6.46%
Short Ratio (days to cover) 2.76

Valuation Ratios

The PE ratio is -0.62 and the forward PE ratio is -0.71. Sutro Biopharma's PEG ratio is -0.01.

PE Ratio -0.62
Forward PE -0.71
PS Ratio 2.28
Forward PS 1.1
PB Ratio 3.17
P/FCF Ratio -0.73
PEG Ratio -0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Sutro Biopharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.6, with a Debt / Equity ratio of 0.52.

Current Ratio 2.6
Quick Ratio 2.6
Debt / Equity 0.52
Debt / EBITDA -0.12
Debt / FCF -0.12
Interest Coverage -7.67

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $200.14K
Profits Per Employee $-733.75K
Employee Count 310
Asset Turnover 0.16
Inventory Turnover n/a

Taxes

Income Tax 2.36M
Effective Tax Rate -1.05%

Stock Price Statistics

The stock price has increased by -74.06% in the last 52 weeks. The beta is 1.7, so Sutro Biopharma's price volatility has been higher than the market average.

Beta 1.7
52-Week Price Change -74.06%
50-Day Moving Average 1.08
200-Day Moving Average 2.69
Relative Strength Index (RSI) 57.09
Average Volume (20 Days) 1.57M

Income Statement

In the last 12 months, Sutro Biopharma had revenue of 62.04M and earned -227.46M in profits. Earnings per share was -2.96.

Revenue 62.04M
Gross Profit 62.04M
Operating Income -238.45M
Net Income -227.46M
EBITDA -186.81M
EBIT -194.03M
Earnings Per Share (EPS) -2.96
Full Income Statement

Balance Sheet

The company has 190.3M in cash and 23.15M in debt, giving a net cash position of 167.15M.

Cash & Cash Equivalents 190.3M
Total Debt 23.15M
Net Cash 167.15M
Retained Earnings -786.87M
Total Assets 387.21M
Working Capital 211.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -191.54M and capital expenditures -3.1M, giving a free cash flow of -194.64M.

Operating Cash Flow -191.54M
Capital Expenditures -3.1M
Free Cash Flow -194.64M
FCF Per Share -2.53
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -384.34% and -366.62%.

Gross Margin 100%
Operating Margin -384.34%
Pretax Margin -362.81%
Profit Margin -366.62%
EBITDA Margin -301.1%
EBIT Margin -384.34%
FCF Margin -313.71%

Dividends & Yields

STRO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for STRO is $10, which is 1011.1% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 1011.1%
Analyst Consensus Buy
Analyst Count 8
Stock Forecasts

Scores

Altman Z-Score -3.57
Piotroski F-Score 2